DSIP (Delta Sleep-Inducing Peptide)

This is the foundational paper describing the isolation and characterization of DSIP. The Swiss group at Basel collected extracorporeal dialysate of cerebral venous blood from rabbits undergoing hypnogenic electrical stimulation of the intralaminar thalamic area. Through successive purification steps, they isolated a nonapeptide fraction that, when infused into the mesodiencephalic ventricle of recipient rabbits, induced spindle and delta EEG activity along with reduced motor activity. Amino-acid analysis and sequencing identified the structure as Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Synthetic peptide prepared to match this sequence reproduced the EEG delta-enhancement effect under double-blind testing in rabbits, leading the authors to name the substance Delta Sleep-Inducing Peptide.

This is the original 1977 paper that put DSIP on the map. Swiss researchers collected fluid from the brains of sleeping rabbits and purified a small peptide out of it. When they injected that purified peptide — or a lab-made copy of the same 9-amino-acid sequence — into other rabbits, the recipient animals showed more deep-sleep "delta" brain waves on their EEG. That's how the peptide got its name. The work was careful for its era, but it's also where the entire DSIP story begins, and later researchers have pointed out that the original effects have been harder to reproduce in some species than the name implies.

This review, published nearly three decades after DSIP's discovery, evaluates the cumulative evidence for the peptide's identity, mechanism, and biological activity. The authors document several outstanding gaps: no DSIP precursor protein has been isolated, no gene encoding the nonapeptide sequence has been identified in mammalian genomes, no specific DSIP receptor has been cloned, and immunoreactive "DSIP-like" material detected in tissues has not been unambiguously matched to the WAGGDASGE sequence. They survey the reported neuroendocrine effects — including modulation of ACTH, cortisol, somatostatin, and luteinizing hormone in various preparations — and note that observed activity is inconsistent across labs and species. The authors conclude that DSIP remains an experimentally interesting but mechanistically uncharacterized molecule.

This 2006 review is the honest counterweight to the 1977 discovery paper. Two researchers looked back at everything published on DSIP and asked: what do we actually know? Their answer is "less than the name suggests." Nobody has found the gene that makes DSIP in the body. Nobody has found the receptor it binds to. Different labs studying it get different results. The peptide clearly does something in some experiments, but the underlying mechanism is still an open question. We include this paper alongside the original 1977 work so researchers see both sides of the literature.